Literature DB >> 20577861

Vascular endothelial growth factor concentrations in aqueous humor before and after subconjunctival injection of bevacizumab for neovascular glaucoma.

Masanori Mizote, Tetsuya Baba, Kazuyuki Hirooka, Hidetaka Yamaji, Fumio Shiraga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20577861     DOI： 10.1007/s10384-009-0788-y

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN： 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy.

Authors:  Yusuke Oshima; Hirokazu Sakaguchi; Fumi Gomi; Yasuo Tano
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

2.  The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.

Authors:  A E Fung; P J Rosenfeld; E Reichel
Journal:  Br J Ophthalmol       Date:  2006-07-19       Impact factor: 4.638

3.  Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.

Authors:  Osamu Sawada; Hajime Kawamura; Masashi Kakinoki; Tomoko Sawada; Masahito Ohji
Journal:  Arch Ophthalmol       Date:  2007-10

4.  Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.

Authors:  Hiroyuki Nomoto; Fumio Shiraga; Noriyuki Kuno; Erika Kimura; Shinobu Fujii; Katsuhiko Shinomiya; Alex K Nugent; Kazuyuki Hirooka; Tetsuya Baba
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-25       Impact factor: 4.799

5.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245
  5 in total
  2 in total

1.  Regression of iris neovascularization after subconjunctival injection of bevacizumab.

Authors:  Na Kyung Ryoo; Eun Ji Lee; Tae-Woo Kim
Journal:  Korean J Ophthalmol       Date:  2013-07-18

2.  Vascular endothelial growth factor in anterior chamber liquid patients with diabetic retinopathy, cataract and neovascular glaucoma.

Authors:  Anatoly Kuzmin; Dmitry Lipatov; Timofei Chistyakov; Olga Smirnova; Margarita Arbuzova; Alexander Ilin; Marina Shestakova; Ivan Dedov
Journal:  Ophthalmol Ther       Date:  2013-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.